Bracket: PE investment to support growth, innovation

The private equity firm, Genstar capital, has acquired the clinical trial technology and specialty services provider, Bracket.

Jeff Kinell, Bracket’s CEO, told us the company is “very excited” about the opportunity.

Genstar has a great track record in this area, and we think they will be a great partner for us," he added.

Genstar's current and previous investments in healthcare technology and services companies include ERT, ConnectiveRx, Netsmart, and PRA International.

"Genstar brings experience and stability. With Genstar's backing, we can proceed with growth investments and strategic acquisitions to expand our product capabilities,” Kinell said. “This will allow us to continue to innovate in our technology development, something our clients have come to expect."

Moving forward, the company structure, management team, employees, and offices are all “staying the course,” Kinell explained, though the company has plans for growth and hiring at all of its locations this year. Ultimately, “this transition should be largely unnoticeable to both employees and clients," he said.